LanthaScreen™ TR-FRET Glucocorticoid Receptor Coactivator Assay Kit
LanthaScreen™ TR-FRET Glucocorticoid Receptor Coactivator Assay Kit

LanthaScreen™ TR-FRET Glucocorticoid Receptor Coactivator Assay Kit

El kit de ensayo del coactivador del receptor de glucocorticoides LanthaScreen™ TR-FRET proporciona un método sensible y robusto para elMás información
Have Questions?
Número de catálogoCantidad
A15899800 ensayos de 20 μL
Número de catálogo A15899
Precio (CLP)
-
Cantidad:
800 ensayos de 20 μL
El kit de ensayo del coactivador del receptor de glucocorticoides LanthaScreen™ TR-FRET proporciona un método sensible y robusto para el cribado analítico masivo de los potenciales ligandos de receptor de glucocorticoides (GR) como agonistas o antagonistas del reclutamiento de coactivador dependiente de ligando. El kit utiliza un dominio de unión a ligando GR (GR-LBD) recombinante humano marcado con glutatión S-transferasa (GST) (también disponible por separado), un anticuerpo anti-GST marcado con terbio (Tb) y un péptido coactivador marcado con fluoresceína en un formato de ensayo homogéneo de mezcla y lectura.

Modo agonista
Al ejecutar el ensayo de coactivador del receptor de glucocorticoides LanthaScreen TR-FRET en modo agonista (para identificar compuestos agonistas), se añade GR-LBD a los compuestos de ensayo de ligando, seguido de la adición de una mezcla de péptido coactivador de fluoresceína y anticuerpo anti-GST marcado con Tb. Después de una incubación a temperatura ambiente, se calcula la relación TR-FRET de 520/495 nm y se puede utilizar para determinar la EC50 a partir de una curva de respuesta de dosis del compuesto. Basado en la biología de la interacción del péptido GR-coactivador, este ligando EC50 es un valor compuesto que representa la cantidad de ligando necesaria para unirse al receptor, efectuar un cambio conformacional, y reclutar el péptido coactivador (consulte la figura).

Modo antagonista
Cuando el ensayo de coactivador del receptor de glucocorticoides LanthaScreen TR-FRET se ejecuta en modo antagonista (para identificar compuestos antagonistas), se agrega GR-LBD a los compuestos de prueba de ligando, seguido de la adición de una mezcla de agonista, péptido coactivador de fluoresceína y anticuerpo anti-GST marcado con Tb. La concentración de agonista utilizada en este modo es la concentración de EC80 determinada por la primera ejecución del ensayo en modo agonista.
Para uso exclusivo en investigación. No apto para uso en procedimientos diagnósticos.
Especificaciones
Para utilizar con (aplicación)Ensayo de interacción de cofactores, ensayo de receptores nucleares
Línea de productosLanthaScreen
Cantidad800 ensayos de 20 μL
TipoKit de ensayo de coactivadores del receptor de glucocorticoides TR-FRET
Unit SizeEach
Contenido y almacenamiento
1 tubo de proteína recombinante de dominio de unión de ligando GR (almacenar entre -68 y -85 °C)
1 tubo de péptido (almacenar entre -5 y -30 °C)
2 frascos de tampón TR-FRET (almacenar entre -5 y -30 °C)
1 vial de Tb-Anti-GST Ab (almacenar entre -5 y -30 °C)
1 tubo de DTT (almacenar entre -5 y -30 °C)

Preguntas frecuentes

Will I need to update my TaqMan hPSC Scorecard Analysis Software?

No software update is required. Because the hPSC Scorecard Analysis Software is cloud based, you will always have access to the most up-to-date version of the software every time you log in.

Find additional tips, troubleshooting help, and resources within our Real-Time PCR and Digital PCR Applications Support Center

How does the LanthaScreen technology compare to other TR-FRET assay formats?

We performed a comparison between the LanthaScreen assay and other commercially available TR-FRET assays from 2 different suppliers for the PKC kinase target. Our data revealed that the assays performed comparably, but that the LanthaScreen assay was simpler to optimize and contained fewer components that required optimization. The LanthaScreen assay is a two component system, whereas the other assay formats utilize a trimolecular mechanism which is more time consuming to optimize and has added costs.

For my kinase assay, can I pre-mix the Tb-Ab and EDTA so that I can stop the kinase assay and begin detection with a single reagent addition?

Yes, this is possible depending on the concentrations of reagents used and the time for which they are mixed. We recommend developing and optimizing the assay by using separate reagent additions, because this method will work under the widest range of conditions. Once the assay is optimized, the performance of the assay using pre-mixed antibody and EDTA can be evaluated. We have successfully developed robust assays in which the antibody and EDTA were pre-mixed and then stored overnight at 4 degrees C prior to use the following day. A loss of signal intensity was observed in this case, however, by using the ratiometric readout, this effect was minimal.

Are the LanthaScreen reagents stable to interference from Mg2+, Mn2+, and EDTA?

The chelate is completely stable to Mg2+. The amount of Mn2+ or EDTA that the chelate can tolerate depends largely on how long they are mixed together and the combination of additives used in the reaction. If a reaction requires either Mg2+ or Mn2+ for activation, it is best to stop the reaction by adding an equimolar amount (or slight excess) of EDTA to chelate the metal ions present. This will then essentially eliminate any interference on the terbium chelate by EDTA or Mn2+. Regardless, when LanthaScreen assays are performed using a ratiometric readout (division of the acceptor signal by the donor signal), any interference caused by Mn2+ or EDTA is largely cancelled out.

What is the optimal and/or maximum distance for a Tb-fluorescein pair?

The Förster radius, the distance at which energy transfer efficiency is half-maximal, is around 50-angstroms for the terbiumÆ fluorescein pair. However, the Förster radius does not give a complete indication of energy transfer efficiency when using long lifetime fluorophores such as terbium chelates. When using terbium chelates, energy transfer efficiency is determined by the distance of closest approach between the donor and acceptor during the excited state lifetime of the donor. In many assay systems, such as those designed using antibodies or peptides, there is a large degree of conformational freedom that allows the donor and acceptor to approach one another, effectively enhancing the FRET signal. Additionally, it is important to note that as the donor/acceptor pair approach one another and the efficiency of energy transfer increases, the fluorescent lifetime decreases to a comparable extent. From a practical standpoint, this means that when energy transfer is extremely efficient, FRET cannot be measured in time-resolved mode (because the energy transfer is complete before the measurement is made). This is another reason why TR-FRET assays based around terbium-labeled antibodies or streptavidin perform so well, because there exist a range of donor/acceptor distances, several of which are optimal for measuring FRET.